| CAS No 17849-38-6 |
2-Chlorobenzyl alcoholnull |
Inquiry |
| CAS No 161599-46-8 |
2',3'-DI-O-ACETYL-5'-DEOXY-5-FLUOROCYTIDINEnull |
Inquiry |
| CAS No 15484-46-5 |
2-Propenoic acid,2-(hydroxymethyl)-, methyl esternull |
Inquiry |
| CAS No 154212-60-9 |
1-(2-Isopropylthiazol-4-yl)-N-methyl methanaminenull |
Inquiry |
| CAS No 152-11-4 |
Verapamil hydrochloridenull |
Inquiry |
| CAS No 148893-10-1 |
HATUnull |
Inquiry |
| CAS No 147-24-0 |
Diphenhydramine hydrochloridenull |
Inquiry |
| CAS No 144163-97-3 |
Carbonic acid 4-nitrophenyl 5-thiazolylmethyl esternull |
Inquiry |
| CAS No 141315-50-6 |
(S)-(+)-(o-Chlorophenyl)glycinenull |
Inquiry |
| CAS No 14189-82-3 |
3-(N-Phenyl-N-methyl)aminoacroleinnull |
Inquiry |
| CAS No 141109-19-5 |
S-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloridenull |
Inquiry |
| CAS No 133627-45-9 |
3-Amino-2-chloro-4-methyl pyridinenull |
Inquiry |
| CAS No 13422-55-4 |
Mecobalaminnull |
Inquiry |
| CAS No 13139-17-8 |
Nα-(Benzyloxycarbonyloxy) Succinimidenull |
Inquiry |
| CAS No 128625-52-5 |
Benzotriazol-1-yl-oxytripyrrolidino-phosphonium Hexafluorophosphatenull |
Inquiry |
| CAS No 129332-29-2 |
t-Butyl(E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-6-heptenoatenull |
Inquiry |
| CAS No 125995-13-3 |
(4R,6R)-t-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetatenull |
Inquiry |
| CAS No 125700-67-6 |
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroboratenull |
Inquiry |
| CAS No 125971-96-2 |
4-FLUORO-alpha-(2-METHYL-1-OXOPROPYL)-gama-OXO-N,beta-DIPHENYLBENZENE BUTANEAMIDE (M4)null |
Inquiry |
| CAS No 120-20-7 |
2-(3,4-Dimethoxy phenyl)ethyl aminenull |
Inquiry |
| CAS No 115473-15-9 |
Thieno[3,2-c]pyridin-2(4H)-one,5,6,7,7a-tetrahydro-, hydrochloride (1:1)null |
Inquiry |
| CAS No 10421-85-9 |
2-chloromandelic acidnull |
Inquiry |
| CAS No 105484-55-7 |
Octanoic acid,8-chloro-, ethyl esternull |
Inquiry |
| CAS No 10226-30-9 |
6-Chloro-2-hexanonenull |
Inquiry |
| CAS No 102029-44-7 |
(R)-4-Benzyl-2-oxazolidinonenull |
Inquiry |
